<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<ReleaseSet Dated="2016-07-04" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" Type="full" xsi:noNamespaceSchemaLocation="http://ftp.ncbi.nlm.nih.gov/pub/clinvar/xsd_public/clinvar_public_1.35.xsd">

<ClinVarSet ID="47180809"><RecordStatus>current</RecordStatus><Title>NM_000520.6(HEXA):c.986+3A&gt;G AND Tay-Sachs disease</Title><ReferenceClinVarAssertion DateCreated="2015-03-29" DateLastUpdated="2019-11-02" ID="399359"><ClinVarAccession Acc="RCV000169296" Version="5" Type="RCV" DateUpdated="2019-11-02" /><RecordStatus>current</RecordStatus><ClinicalSignificance DateLastEvaluated="2018-09-19"><ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus><Description>Pathogenic/Likely pathogenic</Description></ClinicalSignificance><Assertion Type="variation to disease" /><AttributeSet><Attribute Type="ModeOfInheritance" integerValue="263">Autosomal recessive inheritance</Attribute><XRef ID="28566" DB="Counsyl" /></AttributeSet><ObservedIn><Sample><Origin>germline</Origin><Species TaxonomyId="9606">human</Species><AffectedStatus>unknown</AffectedStatus></Sample><Method><MethodType>clinical testing</MethodType></Method><ObservedData ID="48060286"><Attribute Type="Description">not provided</Attribute></ObservedData><ObservedData ID="48060286"><Attribute Type="Description">not provided</Attribute></ObservedData><ObservedData ID="48060286"><Attribute Type="Description">not provided</Attribute></ObservedData></ObservedIn><ObservedIn><Sample><Origin>maternal</Origin><Species TaxonomyId="9606">human</Species><AffectedStatus>unknown</AffectedStatus><NumberTested>1</NumberTested></Sample><Method><MethodType>research</MethodType></Method><ObservedData ID="48062139"><Attribute integerValue="1" Type="VariantAlleles" /></ObservedData><ObservedData ID="48062139"><Attribute Type="SampleLocalID">15:72641417:T:00364C</Attribute></ObservedData></ObservedIn><ObservedIn><Sample><Origin>unknown</Origin><Species TaxonomyId="9606">human</Species><AffectedStatus>unknown</AffectedStatus><NumberTested>1</NumberTested></Sample><Method><MethodType>research</MethodType></Method><Method><MethodType>literature only</MethodType></Method><ObservedData ID="48062140"><Attribute integerValue="1" Type="VariantAlleles" /></ObservedData><ObservedData ID="48062140"><Attribute Type="Description">not provided</Attribute></ObservedData><ObservedData ID="48062140"><Attribute Type="SampleLocalID">15:72641417:T:00364M</Attribute></ObservedData></ObservedIn><MeasureSet Type="Variant" ID="188929" Acc="VCV000188929" Version="4"><Measure Type="single nucleotide variant" ID="186936"><Name><ElementValue Type="Preferred">NM_000520.6(HEXA):c.986+3A&gt;G</ElementValue></Name><AttributeSet><Attribute Accession="NM_001318825" Version="2" Change="c.1019+3A&gt;G" Type="HGVS, coding, RefSeq">NM_001318825.2:c.1019+3A&gt;G</Attribute></AttributeSet><AttributeSet><Attribute Accession="NM_000520" Version="6" Change="c.986+3A&gt;G" Type="HGVS, coding, RefSeq">NM_000520.6:c.986+3A&gt;G</Attribute></AttributeSet><AttributeSet><Attribute Accession="NG_009017" Version="1" Change="g.32104A&gt;G" Type="HGVS, genomic, RefSeqGene">NG_009017.1:g.32104A&gt;G</Attribute></AttributeSet><AttributeSet><Attribute Accession="NG_009017" Version="2" Change="g.32104A&gt;G" Type="HGVS, genomic, RefSeqGene">NG_009017.2:g.32104A&gt;G</Attribute></AttributeSet><AttributeSet><Attribute Accession="NC_000015" Version="10" Change="g.72349076T&gt;C" Type="HGVS, genomic, top level" integerValue="38">NC_000015.10:g.72349076T&gt;C</Attribute></AttributeSet><AttributeSet><Attribute Accession="NC_000015" Version="9" Change="g.72641417T&gt;C" Type="HGVS, genomic, top level, previous" integerValue="37">NC_000015.9:g.72641417T&gt;C</Attribute></AttributeSet><AttributeSet><Attribute Accession="NM_000520" Version="4" Change="c.986+3A&gt;G" Type="HGVS, previous">NM_000520.4:c.986+3A&gt;G</Attribute></AttributeSet><AttributeSet><Attribute Type="MolecularConsequence">intron variant</Attribute><XRef ID="SO:0001627" DB="Sequence Ontology" /><XRef ID="NM_000520.6:c.986+3A&gt;G" DB="RefSeq" /></AttributeSet><AttributeSet><Attribute Type="MolecularConsequence">intron variant</Attribute><XRef ID="SO:0001627" DB="Sequence Ontology" /><XRef ID="NM_001318825.2:c.1019+3A&gt;G" DB="RefSeq" /></AttributeSet><AlleleFrequencyList><AlleleFrequency Value="0.00008" Source="NHLBI Exome Sequencing Project (ESP) Exome Variant Server" /><AlleleFrequency Value="0.00020" Source="1000 Genomes Project" /><AlleleFrequency Value="0.00002" Source="Exome Aggregation Consortium (ExAC)" /><AlleleFrequency Value="0.00002" Source="The Genome Aggregation Database (gnomAD), exomes" /><AlleleFrequency Value="0.00004" Source="Trans-Omics for Precision Medicine (TOPMed)" /></AlleleFrequencyList><GlobalMinorAlleleFrequency Value="0.00020" Source="1000 Genomes Project" MinorAllele="C" /><CytogeneticLocation>15q23</CytogeneticLocation><SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="72349076" stop="72349076" display_start="72349076" display_stop="72349076" variantLength="1" positionVCF="72349076" referenceAlleleVCF="T" alternateAlleleVCF="C" /><SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="72641417" stop="72641417" display_start="72641417" display_stop="72641417" variantLength="1" positionVCF="72641417" referenceAlleleVCF="T" alternateAlleleVCF="C" /><MeasureRelationship Type="within single gene"><Name><ElementValue Type="Preferred">hexosaminidase subunit alpha</ElementValue></Name><Symbol><ElementValue Type="Preferred">HEXA</ElementValue></Symbol><SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="72340924" stop="72376014" display_start="72340924" display_stop="72376014" Strand="-" /><SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="72635777" stop="72668519" display_start="72635777" display_stop="72668519" variantLength="32743" Strand="-" /><XRef ID="3073" DB="Gene" /><XRef Type="MIM" ID="606869" DB="OMIM" /><XRef ID="HGNC:4878" DB="HGNC" /></MeasureRelationship><XRef ID="1360913" DB="Illumina Clinical Services Laboratory,Illumina" /><XRef Type="rs" ID="200926928" DB="dbSNP" /></Measure><Name><ElementValue Type="Preferred">NM_000520.6(HEXA):c.986+3A&gt;G</ElementValue></Name><XRef ID="CA274144" DB="ClinGen" /></MeasureSet><TraitSet Type="Disease" ID="1067"><Trait ID="6027" Type="Disease"><Name><ElementValue Type="Preferred">Tay-Sachs disease</ElementValue><XRef ID="Tay+Sachs+disease/7008" DB="Genetic Alliance" /><XRef ID="tay-sachs-disease" DB="Genetics Home Reference" /><XRef ID="111385000" DB="SNOMED CT" /></Name><Symbol><ElementValue Type="Preferred">TSD</ElementValue><XRef Type="MIM" ID="272800" DB="OMIM" /><XRef ID="7737" DB="Office of Rare Diseases" /></Symbol><AttributeSet><Attribute Type="public definition">Hexosaminidase A deficiency results in a group of neurodegenerative disorders caused by intralysosomal storage of the specific glycosphingolipid, GM2 ganglioside. The prototype hexosaminidase A deficiency is Tay-Sachs disease, also known as the acute infantile variant. Tay-Sachs disease is characterized by progressive weakness, loss of motor skills, decreased attentiveness, and increased startle response beginning between ages three and six months with progressive evidence of neurodegeneration including: seizures, blindness, spasticity, eventual total incapacitation, and death, usually before age four years. The juvenile (subacute), chronic, and adult-onset variants of hexosaminidase A deficiency have later onsets, slower progression, and more variable neurologic findings, including: progressive dystonia, spinocerebellar degeneration, motor neuron disease, and, in some individuals with adult-onset disease, a bipolar form of psychosis.</Attribute><XRef ID="NBK1218" DB="GeneReviews" /></AttributeSet><Citation Type="review" Abbrev="GeneReviews"><ID Source="PubMed">20301397</ID><ID Source="BookShelf">NBK1218</ID></Citation><Citation Type="practice guideline" Abbrev="ACMG, 2008"><ID Source="PubMed">18197057</ID></Citation><Citation Type="practice guideline" Abbrev="ACOG, 2009"><ID Source="PubMed">19888064</ID></Citation><XRef ID="C0039373" DB="MedGen" /><XRef ID="845" DB="Orphanet" /><XRef Type="MIM" ID="272800" DB="OMIM" /></Trait></TraitSet></ReferenceClinVarAssertion><ClinVarAssertion ID="397371" SubmissionName="Counsyl_2015_03_01"><ClinVarSubmissionID localKey="NM_000520.4(HEXA):c.986+3A&gt;G" localKeyIsSubmitted="1" submitter="Counsyl" submitterDate="2015-03-11" /><ClinVarAccession Acc="SCV000220615" Version="1" Type="SCV" OrgID="320494" OrganizationCategory="laboratory" OrgType="primary" DateUpdated="2019-03-31" /><RecordStatus>current</RecordStatus><ClinicalSignificance DateLastEvaluated="2014-08-21"><ReviewStatus>criteria provided, single submitter</ReviewStatus><Description>Likely pathogenic</Description><Citation><ID Source="PubMed">23035047</ID></Citation><Citation><ID Source="PubMed">7551830</ID></Citation><Citation><ID Source="PubMed">24518553</ID></Citation></ClinicalSignificance><Assertion Type="variation to disease" /><ExternalID DB="Counsyl" ID="28566" /><AttributeSet><Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute></AttributeSet><AttributeSet><Attribute Type="AssertionMethod">Counsyl Autosomal and X-linked Recessive Disease Classification criteria (2015)</Attribute><Citation Type="general"><URL>https://submit.ncbi.nlm.nih.gov/ft/byid/4yisoce9/mdi-5618_320494_counsyl_autosomal_and_x-linked_recessive_disease_classification_criteria_(2015).pdf</URL><CitationText>Counsyl Autosomal and X-linked Recessive Disease Classification criteria (2015)</CitationText></Citation></AttributeSet><ObservedIn><Sample><Origin>unknown</Origin><Species TaxonomyId="9606">human</Species><AffectedStatus>unknown</AffectedStatus></Sample><Method><MethodType>literature only</MethodType></Method><ObservedData><Attribute Type="Description">not provided</Attribute></ObservedData></ObservedIn><MeasureSet Type="Variant"><Measure Type="Variation"><AttributeSet><Attribute Type="HGVS">NM_000520.4:c.986+3A&gt;G</Attribute></AttributeSet><MeasureRelationship Type="variant in gene"><Symbol><ElementValue Type="Preferred">HEXA</ElementValue></Symbol></MeasureRelationship></Measure></MeasureSet><TraitSet Type="Disease"><Trait Type="Disease"><Name><ElementValue Type="Preferred">Tay-Sachs disease</ElementValue></Name><XRef DB="OMIM" ID="272800" Type="MIM" /></Trait></TraitSet></ClinVarAssertion><ClinVarAssertion ID="1139226" SubmissionName="SUB2844653"><ClinVarSubmissionID localKey="15:72641417:T" localKeyIsSubmitted="1" submittedAssembly="GRCh37" submitter="HudsonAlpha Institute for Biotechnology, HudsonAlpha Institute for Biotechnology" submitterDate="2017-07-06" /><ClinVarAccession Acc="SCV000584096" Version="1" Type="SCV" OrgID="505530" OrganizationCategory="laboratory" OrgType="primary" DateUpdated="2019-08-30" /><RecordStatus>current</RecordStatus><ClinicalSignificance DateLastEvaluated="2016-10-13"><ReviewStatus>criteria provided, single submitter</ReviewStatus><Description>Pathogenic</Description></ClinicalSignificance><Assertion Type="variation to disease" /><ExternalID DB="HudsonAlpha Institute for Biotechnology" ID="15:72641417" /><AttributeSet><Attribute Type="AssertionMethod">HA_assertions_20150911</Attribute><Citation Type="general"><URL>https://submit.ncbi.nlm.nih.gov/ft/byid/suocabs5/ha_assertions_20150911.pdf</URL><CitationText>HA_assertions_20150911.pdf</CitationText></Citation></AttributeSet><ObservedIn><Sample><Origin>unknown</Origin><Species TaxonomyId="9606">human</Species><AffectedStatus>unknown</AffectedStatus><NumberTested>1</NumberTested></Sample><Method><MethodType>research</MethodType></Method><ObservedData><Attribute Type="VariantAlleles" integerValue="1" /></ObservedData><ObservedData><Attribute Type="SampleLocalID">15:72641417:T:00364M</Attribute></ObservedData></ObservedIn><ObservedIn><Sample><Origin>maternal</Origin><Species TaxonomyId="9606">human</Species><AffectedStatus>unknown</AffectedStatus><NumberTested>1</NumberTested></Sample><Method><MethodType>research</MethodType></Method><ObservedData><Attribute Type="VariantAlleles" integerValue="1" /></ObservedData><ObservedData><Attribute Type="SampleLocalID">15:72641417:T:00364C</Attribute></ObservedData></ObservedIn><MeasureSet Type="Variant"><Measure Type="Variation"><SequenceLocation Assembly="GRCh37" Chr="15" alternateAllele="C" referenceAllele="T" start="72641417" stop="72641417" variantLength="1" /><MeasureRelationship Type="variant in gene"><Symbol><ElementValue Type="Preferred">HEXA</ElementValue></Symbol></MeasureRelationship></Measure></MeasureSet><TraitSet Type="Disease"><Trait Type="Disease"><XRef DB="OMIM" ID="272800" Type="MIM" /></Trait></TraitSet><StudyName>CSER-HudsonAlpha</StudyName></ClinVarAssertion><ClinVarAssertion ID="1789761" SubmissionName="SUB5118208"><ClinVarSubmissionID localKey="1365825" localKeyIsSubmitted="1" submittedAssembly="GRCh37" submitter="Illumina Clinical Services Laboratory,Illumina" submitterDate="2019-02-01" /><ClinVarAccession Acc="SCV000914693" Version="1" Type="SCV" OrgID="504895" OrganizationCategory="laboratory" OrgType="primary" DateUpdated="2019-05-24" /><RecordStatus>current</RecordStatus><ClinicalSignificance DateLastEvaluated="2017-09-08"><ReviewStatus>criteria provided, single submitter</ReviewStatus><Description>Likely pathogenic</Description><Citation><ID Source="PubMed">7551830</ID></Citation><Citation><ID Source="PubMed">9150157</ID></Citation><Citation><ID Source="PubMed">20100466</ID></Citation><Citation><ID Source="PubMed">23035047</ID></Citation><Comment Type="public">The HEXA c.986+3A&gt;G splice region variant has been reported in at least four studies in which it is found in a total of three patients in a compound heterozygous state and in a heterozygous state in one obligate carrier (Richard et al. 1995; Akerman et al. 1997; Giraud et al. 2010; Saunders et al. 2012). One compound heterozygote presented with the late-infantile onset form of Tay-Sachs disease while another compound heterozygote had onset in adulthood. Control data are unavailable for this variant which is reported at a frequency of 0.000025 in the total population from the Exome Aggregation Consortium. In one study, exons 7 to 9 of the c.986+3A&gt;G variant HEXA were amplified and the resulting mRNA product was shown to be lacking exon 8, suggesting this variant affects splicing (Richard et al. 1995). Based on the evidence, the c.986+3A&gt;G variant is classified as likely pathogenic for hexoaminidase A deficiency. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.</Comment></ClinicalSignificance><Assertion Type="variation to disease" /><ExternalID DB="Illumina Clinical Services Laboratory" ID="1360913" /><AttributeSet><Attribute Type="AssertionMethod">ICSL Variant Classification Criteria 09 May 2019</Attribute><Citation><URL>https://submit.ncbi.nlm.nih.gov/ft/byid/thsgk7t4/icsl_variant_classification_criteria_09_may_2019.pdf</URL></Citation></AttributeSet><ObservedIn><Sample><Origin>germline</Origin><Species TaxonomyId="9606">human</Species><AffectedStatus>unknown</AffectedStatus></Sample><Method><MethodType>clinical testing</MethodType></Method><ObservedData><Attribute Type="Description">not provided</Attribute></ObservedData></ObservedIn><MeasureSet Type="Variant"><Measure Type="Variation"><AttributeSet><Attribute Type="HGVS">NM_000520.4:c.986+3A&gt;G</Attribute></AttributeSet><SequenceLocation Assembly="GRCh37" Chr="15" alternateAllele="C" referenceAllele="T" start="72641417" stop="72641417" variantLength="1" /><MeasureRelationship Type="variant in gene"><Symbol><ElementValue Type="Preferred">HEXA</ElementValue></Symbol></MeasureRelationship></Measure></MeasureSet><TraitSet Type="Disease"><Trait Type="Disease"><XRef DB="OMIM" ID="272800" Type="MIM" /></Trait></TraitSet></ClinVarAssertion><ClinVarAssertion ID="1796126" SubmissionName="SUB5494893"><ClinVarSubmissionID localKey="NM_000520.4:c.986+3A&gt;G|MedGen:C0039373" submittedAssembly="GRCh37" submitter="Integrated Genetics/Laboratory Corporation of America" submitterDate="2019-04-24" /><ClinVarAccession Acc="SCV000919505" Version="1" Type="SCV" OrgID="500026" OrganizationCategory="laboratory" OrgType="primary" DateUpdated="2019-05-31" /><RecordStatus>current</RecordStatus><ClinicalSignificance DateLastEvaluated="2018-04-09"><ReviewStatus>criteria provided, single submitter</ReviewStatus><Description>Pathogenic</Description><Citation><ID Source="PubMed">24518553</ID></Citation><Citation><ID Source="PubMed">20100466</ID></Citation><Citation><ID Source="PubMed">9150157</ID></Citation><Citation><ID Source="PubMed">7551830</ID></Citation><Citation><ID Source="PubMed">23035047</ID></Citation><Comment Type="public">Variant summary: HEXA c.986+3A&gt;G alters a conserved nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. Several computational tools predict a significant impact on normal splicing: Four predict the variant weakens a 5' donor site. A publication, Richard_1995, functionally assessed the variant and found it to cause exon 8 to be deleted, which is located in the Glycoside hydrolase family 20, catalytic domain (via InterPro). The variant was observed with an allele frequency of 8.1e-06 in 246182 control chromosomes (gnomAD). This frequency is not higher than expected for a pathogenic variant in HEXA causing Tay-Sachs Disease (8.1e-06 vs 0.0014), allowing no conclusion about variant significance. The variant, c.986+3A&gt;G, has been reported in the literature in individuals affected with Tay-Sachs Disease. These data indicate that the variant is likely to be associated with disease. A ClinVar submission from a clinical diagnostic laboratory (evaluation after 2014) cites the variant as "likely pathogenic." Based on the evidence outlined above, the variant was classified as pathogenic.</Comment></ClinicalSignificance><Assertion Type="variation to disease" /><AttributeSet><Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute><Citation><URL>https://submit.ncbi.nlm.nih.gov/ft/byid/pttb9itm/labcorp_variant_classification_method_-_may_2015.pdf</URL></Citation></AttributeSet><ObservedIn><Sample><Origin>germline</Origin><Species TaxonomyId="9606">human</Species><AffectedStatus>unknown</AffectedStatus></Sample><Method><MethodType>clinical testing</MethodType></Method><ObservedData><Attribute Type="Description">not provided</Attribute></ObservedData></ObservedIn><MeasureSet Type="Variant"><Measure Type="Variation"><AttributeSet><Attribute Type="HGVS">NM_000520.4:c.986+3A&gt;G</Attribute></AttributeSet><MeasureRelationship Type="variant in gene"><Symbol><ElementValue Type="Preferred">HEXA</ElementValue></Symbol></MeasureRelationship></Measure></MeasureSet><TraitSet Type="Disease"><Trait Type="Disease"><Name><ElementValue Type="Preferred">Tay-Sachs disease</ElementValue></Name><XRef DB="MedGen" ID="C0039373" Type="CUI" /></Trait></TraitSet></ClinVarAssertion><ClinVarAssertion ID="1831704" SubmissionName="SUB5371970"><ClinVarSubmissionID localKey="26592|MedGen:C0039373" submittedAssembly="GRCh37" submitter="Invitae" submitterDate="2019-03-28" /><ClinVarAccession Acc="SCV000937827" Version="1" Type="SCV" OrgID="500031" OrganizationCategory="laboratory" OrgType="primary" DateUpdated="2019-08-13" /><RecordStatus>current</RecordStatus><ClinicalSignificance DateLastEvaluated="2018-09-19"><ReviewStatus>criteria provided, single submitter</ReviewStatus><Description>Pathogenic</Description><Citation><ID Source="PubMed">7551830</ID></Citation><Citation><ID Source="PubMed">24518553</ID></Citation><Citation><ID Source="PubMed">23035047</ID></Citation><Comment>This sequence change falls in intron 8 of the HEXA gene. It does not directly change the encoded amino acid sequence of the HEXA protein, but it affects a nucleotide within the consensus splice site of the intron. This variant is present in population databases (rs200926928, ExAC 0.02%). This variant has been observed in a patient with Tay-Sachs disease (PMID: 7551830) and on the opposite chromosome (in trans) from a pathogenic variant in an individual affected with Tay-Sachs disease (PMID: 23035047). This finding is consistent with autosomal recessive inheritance, and suggests that this variant contributes to disease. This variant was also identified in a individual with Tay-Sachs disease in whom a second variant was not identified (PMID: 24518553). ClinVar contains an entry for this variant (Variation ID: 188929). Experimental studies have shown that this splice site variant leads to the skipping of exon 8 (PMID: 7551830). Nucleotide substitutions within the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site, but this prediction has not been confirmed by published transcriptional studies. For these reasons, this variant has been classified as Pathogenic.</Comment></ClinicalSignificance><Assertion Type="variation to disease" /><ExternalID DB="Invitae" ID="26592" /><AttributeSet><Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute><Citation><ID Source="PubMed">28492532</ID></Citation></AttributeSet><ObservedIn><Sample><Origin>germline</Origin><Species TaxonomyId="9606">human</Species><AffectedStatus>unknown</AffectedStatus></Sample><Method><MethodType>clinical testing</MethodType></Method><ObservedData><Attribute Type="Description">not provided</Attribute></ObservedData></ObservedIn><MeasureSet Type="Variant"><Measure Type="Variation"><AttributeSet><Attribute Type="HGVS">NM_000520.4:c.986+3A&gt;G</Attribute></AttributeSet><MeasureRelationship Type="variant in gene"><Symbol><ElementValue Type="Preferred">HEXA</ElementValue></Symbol></MeasureRelationship></Measure></MeasureSet><TraitSet Type="Disease"><Trait Type="Disease"><Name><ElementValue Type="Preferred">Tay-Sachs disease</ElementValue></Name><XRef DB="MedGen" ID="C0039373" Type="CUI" /></Trait></TraitSet></ClinVarAssertion></ClinVarSet>

</ReleaseSet>